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The Haemophilus surface fibril (Hsf) is an unusually large trimeric auto-
transporter adhesin (TAA) expressed by the most virulent strains of
H. influenzae. Hsf is known to mediate adhesion between pathogen and host,
allowing the establishment of potentially deadly diseases such as epiglottitis,
meningitis and pneumonia. While recent research has suggested that this TAA
might adopt a novel ‘hairpin-like’ architecture, the characterization of Hsf has
been limited to in silico modelling and electron micrographs, with no high-
resolution structural data available. Here, the crystal structure of Hsf putative
domain 1 (PD1) is reported at 3.3 A˚ resolution. The structure corrects the
previous domain annotation by revealing the presence of an unexpected
N-terminal TrpRing domain. PD1 represents the first Hsf domain to be solved,
and thus paves the way for further research on the ‘hairpin-like’ hypothesis.
1. Introduction
Haemophilus influenzae is a Gram-negative, facultative
anaerobic bacterium that commonly causes upper respiratory
tract infections, pneumonia and acute meningitis (Danovaro-
Holliday et al., 2008; Murphy et al., 2009). Different strains of
H. influenzae are either encapsulated or unencapsulated, with
the former subdivided into serotypes a–f and the latter
described as nontypeable (Barenkamp & St Geme, 1996).
H. influenzae infection is established by adherence of the
pathogen to the host epithelial cell linings and various extra-
cellular matrix (ECM) proteins (e.g. vitronectin), in a process
mediated by many pilus and nonpilus adhesive factors (Cotter
et al., 2005; Virkola et al., 2000; Hallstro¨m et al., 2006).
Adhesion allows the bacterium to avoid clearance by the host,
and facilitates the establishment of a deep-seated infection
via numerous virulence mechanisms. While all strains of
H. influenzae are pathogenic, it is the virulent type b (Hib)
that, before the introduction of an effective vaccine in the
1990s, accounted for the greatest rates of patient morbidity
and mortality. One such virulence factor utilized by Hib is the
Haemophilus surface fibril (Hsf), a trimeric autotransporter
adhesin (TAA) protein that shares significant homology with
another, better-characterized H. influenzae TAA known as
Hia (Cotter et al., 2005; Singh et al., 2015).
TAAs, which are part of the type V family of secreted
proteins, have three major types of domains arranged in a
linear fibril ‘lollipop’ structure. Head and stalk domains are
interspersed from the N-terminus in the extracellular region.
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Head domains, which are formed from -sheets with either
transversal architectures, such as the YadA-like (YIhead)
domains (Nummelin et al., 2004), or interleaved architectures,
such as the tryptophan-ring (TrpRing) domains (Szczesny et
al., 2008), typically mediate the adhesive activity of the
proteins. The stalk forms a trimeric coiled-coil structure, with
periodicity varying from heptads to pentadecads depending on
the degree and direction of supercoiling (Hernandez Alvarez
et al., 2010). Finally, the C-terminal translocator domain is a
trimeric -barrel, with each subunit contributing one amphi-
pathic -helix plus four -sheets (Meng et al., 2008). This
domain is responsible for the translocation of the remainder of
the protein through the membrane and is found in all TAAs
(Lehr et al., 2010). The highly conserved nature of this domain
is in contrast to the diversity observed in the TAA stalk and
head domains.
Recent studies have suggested that Hsf has an apparently
novel ‘hairpin-like’ structure, based on EM images (Singh et
al., 2015). In their shared regions, Hia and Hsf have 72%
sequence identity (Hia161–1098 and Hsf1484–2413; Supple-
mentary Fig. S1), but full-length trimeric Hsf (750 kDa) is
more than double the size of Hia (340 kDa). The two
binding domains of Hia (HiaBD1 and HiaBD2) have also
been identified in Hsf (Laarmann et al., 2002); unlike Hia,
however, Hsf has an additional binding domain (HsfBD3) and
three putative domains, the structure and function of which
are unknown. Moreover, a limited in silico approach to
modelling the domains of Hsf revealed that it is likely to be a
linear TAA of 200 nm in length (Singh et al., 2015). Despite
this, electron micrographs of Hsf expressed in H. influenzae
RM804 appeared to show Hsf not as a linear TAA but as a
double-folded hairpin-loop structure. Mapping of the domain
arrangement suggested that the N-terminus of Hsf is located
close to the membrane, consistent with the ‘hairpin-like’
hypothesis.
In addition to its adhesive function, Hsf has been shown to
bind the complement inhibitor vitronectin (Vn): the inter-
action has been mapped to HsfBD2 and the C-terminal Vn
residues 352–374 (Hallstro¨m et al., 2006; Singh et al., 2014).
Acquisition of this glycoprotein, which is found in both serum
and the ECM, allows H. influenzae to evade the complement
system and adhere better to the epithelial surface, augmenting
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Figure 1
SDS–PAGE, native PAGE and SEC-MALLS demonstrating that the PD1 domains cause irreversible aggregation. (a) SEC-MALLS chromatogram of
IMAC-purified PD1-GCN4. The degree of aggregation, as observed by the LS peak at the void volume (5 min), the multiple dRI and UV peaks, and an
incorrect molecular weight, demonstrated that the purified protein was not amenable to crystallization. (b) Native PAGE of PD1-GCN4 in the presence
of increasing concentrations of urea. Increasing the urea concentration had no effect on migration and hence no effect on aggregation. Lane 1, carbonic
anhydrase; lanes 3–7, PD1-GCN4 in urea at varying (0, 0.5, 1, 2 and 4M) concentrations. (c) SDS–PAGE of HsfPD1 purified by IMAC (lanes 1–8) and
SEC (lanes 9–13). High levels of expression were evident (lanes 4, 5 and 6) after the proteins were separated on a gradient gel (4–20%) and visualized
with Coomassie Blue. Lane M, molecular-weight marker (labelled in kDa); lane 1, unbound; lanes 2–3 and 8, wash; lanes 4–7, IMAC elution fractions;
lanes 9–13, SEC fractions. (d) SEC-MALLS chromatogram of IMAC- and SEC-purified HsfPD1 [the peak corresponds to one SEC fraction, lane 12 in
the SDS–PAGE gel in (c)]. Alignment of the LS, UVand dRI peaks, and a correct molecular weight, confirmed the presence of trimeric, non-aggregating
protein.
bacterial virulence. This may partly explain why, in contrast to
Hia, Hsf is expressed in the most virulent, typeable strains of
H. influenzae.
Here, we report the crystal structure of a Hsf putative
domain, PD1. This structure reveals a novel domain
arrangement for PD1, N-TrpRing:KG:TrpRing-C, and hence
replaces the domain architecture previously described by in
silico sequence analysis. This work constitutes an ongoing
effort to determine the full-length structure of Hsf in order to
determine whether this TAA adopts the hypothesized novel
‘hairpin-like’ structure (Singh et al., 2015).
2. Materials and methods
2.1. Macromolecule production
2.1.1. PD1-GCN4. The Hsf domain PD1 was cloned
between two GCN4 anchor proteins. GCN4 is a well char-
acterized yeast transcription factor that forms a coiled-coil
dimer in its native state. However, mutagenesis of specific
residues in its hydrophobic core allows GCN4 to adopt various
oligomeric states. Owing to this, variations of GCN4 are often
used as partners for fusion proteins to facilitate stable oligo-
merization. In this case, the idea was to add a well char-
acterized trimer-forming variant of GCN4 to both the N- and
C-terminus to facilitate the stable trimerization of HsfPD1
(Hernandez Alvarez et al., 2008), as successfully used by the
Lupas group in a number of structures (Hartmann et al., 2012;
Koiwai et al., 2016). This fusion protein, PD1-GCN4, was
expressed from a pIBA-PD1-GCN4tri-His6 plasmid generated
using restriction-free (RF) cloning. The PD1 gene was
amplified by polymerase chain reaction from a pET-16b-
hsf 1–2414 plasmid. The primers were designed to generate a
‘megaprimer’ containing the PD1 gene with complementary
overhangs to the destination vector, pIBA-GCN4tri-His6
(Supplementary Table S1). pIBA-GCN4tri-His6 was linearized
by restriction digestion with XhoI (New England Biolabs) and
used as a template in a secondary round of PCR to insert the
PD1 gene (contained within the ‘megaprimer’) into the
plasmid. Expression of PD1-GCN4 was induced at an OD600
of 0.6 by the addition of anhydrotetracycline hydrochloride to
a final concentration of 8.6 mM for 4 h. The cells were
collected by centrifugation (2000g for 10 min at 277 K), stored
at 193 K overnight and resuspended in buffer A consisting of
50 mM NaH2PO4, 500 mM NaCl pH 8.0. The cells were lysed
by sonication and supernatants were collected by centrifuga-
tion (16 000g for 10 min at 277 K). The protein was purified by
immobilized metal ion-affinity chromatography (IMAC). The
cleared supernatant containing PD1-GCN4 was applied onto a
Ni–NTA agarose column (GE Healthcare) previously equili-
brated with buffer A (2  6 ml; three column volumes) and
allowed to bind for 1 h with agitation. Proteins were eluted in
buffer B consisting of 50 mM NaH2PO4, 500 mM NaCl, 10%
glycerol, 300 mM imidazole pH 8.0. The quality of the purified
protein was assessed by size-exclusion chromatography
coupled to a multi-angle laser light scattering (SEC-MALLS)
apparatus (Fig. 1a). SEC-MALLS was carried out using a
Superdex 200 5/150 column pre-equilibrated with buffer C
consisting of 50 mM Tris, 500 mM NaCl, 10% glycerol pH 8.0
at a flow rate of 0.2 ml min1 and was detected using
a DAWN 8+ multi-angle light-scattering (LS) detector, an
Optilab T-rEX differential refractive-index (dRI) detector
and a UV-absorbance (UV) detector (Wyatt).
To prevent the aggregation of PD1-GCN4 (demonstrated
by SEC-MALLS), the purification was repeated in the
presence of increasing concentrations of urea. The protein was
expressed and the cells were lysed as above. Subsequently, the
cleared supernatant was applied onto Ni–NTA agarose resin
(2 ml) and allowed to bind for 1 h with agitation. Purification
was performed in batch mode. The resin was washed with
buffer A (2  6 ml; three column volumes) and then divided
into five equal volumes for elution of protein in different
buffers: buffer B containing 0, 0.5, 1, 2 and 4M urea. The
protein was eluted and fractions were collected for native
PAGE analysis (Fig. 1b).
2.1.2. PD1. Owing to aggregation problems with PD1-
GCN4, we also expressed PD1 from a pET28-PD1-His6
plasmid generated using restriction-free (RF) cloning in the
same way as PD1-GCN4 (x2.1.1). The PD1 gene was amplified
by PCR from the pIBA-PD1-GCN4tri-His6 plasmid using
primers capable of producing a ‘megaprimer’. The pET-28-
Tcfa-His6 destination vector was linearized by restriction
digestion with XhoI and NcoI (New England Biolabs) to
remove the tcfA gene (while retaining the His6 tag). This
plasmid backbone was the template for a secondary round of
PCR, utilizing the ‘megaprimer’, to insert the PD1 gene into
the plasmid (Table 1). Expression of PD1 was induced at an
OD600 of 0.6 by the addition of isopropyl -d-1-thiogalacto-
pyranoside (IPTG) to a final concentration of 0.5 mM for 4 h.
The cells were collected and stored as before (x2.1.1) and
resuspended in buffer C consisting of 50 mM Tris, 150 mM
NaCl pH 8.0. The cells were lysed by sonication and super-
natants were collected by centrifugation (16 000g for 10 min at
277 K). The protein was purified via IMAC on a Ni–NTA
agarose column previously equilibrated with buffer C (2 
6 ml; three column volumes) and allowed to bind for 1 h with
agitation. Proteins were eluted in buffer D consisting of
50 mM Tris, 150 mM NaCl, 300 mM imidazole pH 8.0, and the
pooled fractions were concentrated to 500 ml. Further purifi-
cation was carried out by size-exclusion chromatography
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Table 1
PD1 production information.
Source organism H. influenzae
DNA source pIBA-PD1-GCN4tri-His6
Forward primer GTTTAACTTTAAGAAGGAGATATACCATGGACTT-
TGTTAGTGGAG
Reverse primer GTGGTGGTGGTGCTCGAGGTCTAGTTTTAAGCCA-
TCAGCCAC
Cloning vector pET-28
Expression vector pET-28
Expression host Escherichia coli BL21*
Complete amino-acid sequence
of the construct produced
MDFVSGDKDTTSVTVESKDNGKRTEVKIGAKTSV-
IKDHNGKLFTGKELKDANNNGVTVTETDGKDE-
GNGLVTAKAVIDAVNKAGWRVKTTGANGQNDD-
FATVASGTNVTFADGNGTTAEVTKANDGSITV-
KYNVKVADGLKLD
(SEC) on a Superdex 200 10/300 column pre-equilibrated with
buffer E consisting of 50 mM Tris, 600 mM NaCl pH 8.0 and
eluting imidazole-free protein at a flow rate of 0.2 ml min1.
The purified fractions were then pooled and concentrated to
15 mg ml1 for crystallization. The quality of the purified
protein was assessed prior to crystallization by SDS–PAGE
and SEC-MALLS, carried out as described above, using buffer
C (Fig. 1c and 1d).
2.2. Crystallization
Initial PD1 crystals were obtained using the Wizard Classic
3 and 4 crystallization screens (Molecular Dimensions) using
the following conditions: protein concentration 15 mg ml1,
1M LiCl, 0.1M sodium citrate pH 4, 20%(w/v) polyethylene
glycol (PEG) 6000. Crystallization was performed at 293 K
using the sitting-drop vapour-diffusion method, in which
100 nl protein solution was mixed with an equal volume of
reservoir solution. Drops were set up using a Formulatrix NT8
crystallization robot. Since the initial crystals diffracted
poorly, further crystallization optimization of PD1 was
performed. The best diffracting crystals grew from 0.75M
LiCl, 0.1M sodium citrate pH 3.9, 17.6%(w/v) PEG 6000
(Table 2). Owing to the presence of PEG, this solution already
had cryoprotectant properties and thus the crystals were flash-
cooled directly in liquid nitrogen for data collection.
2.3. Data collection, processing and structure determination
Data were collected on beamline I03 at Diamond Light
Source (DLS). Although radiation damage restricted the data
set to the first 1100 images, the crystals diffracted to 3.3 A˚
resolution (Table 3). Indexing and integration were performed
usingXDS (Kabsch, 2010), while scaling and merging statistics
were calculated using AIMLESS (Evans & Murshudov, 2013).
The structure of PD1 was solved by molecular replacement
(MR) with Phaser (McCoy et al., 2007), using the non-adhesive
domain of Hia307–422 (PDB entry 3emi; Meng et al., 2008;
72.3% sequence identity) as the search model. Phaser found
one unique solution in space group C2, with nine monomers in
the asymmetric unit forming three trimers. The translation-
function Z-score (TFZ) of 39.95 and log-likelihood gain
(LLG) of 2010 indicated a correct MR solution. Refinement
was carried out with PHENIX (Adams et al., 2010), using
secondary-structure and noncrystallographic symmetry
torsion restraints, and the structure was refined to an R factor
of 0.296 (Table 4).
3. Results and discussion
3.1. Purification of PD1-GCN4 and PD1
Initial efforts to purify PD1 utilizing GCN4 anchors (PD1-
GCN4; Hernandez Alvarez et al., 2008; Deiss et al., 2014) were
not successful owing to complete protein aggregation (Fig. 1a).
This was unexpected, as 18 crystal structures of TAA domains
have already been solved using this method. We thought that
the aggregation might be owing to hydrophobic interactions
between the head domains and/or owing to improper folding
of these domains arising from their flanking by the GCN4.
We therefore decided to purify the protein in the presence of
increasing concentrations of urea (0.5–4M) to prevent
aggregation and to use native PAGE to assess the level of
aggregation (Fig. 1b). However, this method was unsuccessful
in reducing aggregation, as the protein still did not migrate as
expected in the gel, suggesting that the GCN4 anchors cause
extensive misfolding and not just a small amount of reversible
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Table 2
Crystallization.
Method Sitting-drop vapour diffusion
Plate type 96-well
Temperature (K) 293
Protein concentration (mg ml1) 15
Buffer composition of protein solution 50 mM Tris, 600 mM NaCl pH 8.0
Composition of reservoir solution 0.75M LiCl, 0.1M sodium citrate
pH 3.9, 17.6%(w/v) PEG 6000
Volume and ratio of drop (nl) 200, 1:1
Volume of reservoir (ml) 50
Table 3
Data collection and processing.
Values in parentheses are for the outer shell.
Diffraction source I03, DLS
Wavelength (A˚) 0.9796
Temperature (K) 100
Detector PILATUS3 6M
Crystal-to-detector distance (mm) 604
Rotation range per image () 0.1
Total rotation range () 110
Exposure time per image (s) 0.1
Space group C2
a, b, c (A˚) 128.4, 50.4, 256.8
, ,  () 90, 101.9, 90
Mosaicity () 0.42
Resolution range (A˚) 29.6–3.3 (3.53–3.30)
Total No. of reflections 50038 (9023)
No. of unique reflections 24219 (4309)
Completeness (%) 97.7 (97.8)
Multiplicity 2.1 (2.1)
hI/(I)i 2.7 (0.9)
Half-set correlation CC1/2 0.962 (0.49)
Rmerge 0.333 (1.14)
Rr.i.m. 0.425 (1.39)
Rp.i.m 0.286 (0.952)
Overall B factor from Wilson plot (A˚2) 62.9
Table 4
Structure solution and refinement.
Values in parentheses are for the outer shell.
Resolution range (A˚) 29.6–3.3 (3.53–3.30)
Completeness (%) 97.6 (97.8)
No. of reflections, working set 24110
No. of reflections, test set 1178
Final Rcryst 0.296
Final Rfree 0.334
No. of non-H protein atoms 8073
R.m.s. deviations
Bonds (A˚) 0.002
Angles () 0.472
Average B factors (A˚2) 58.9
Ramachandran plot
Most favoured (%) 98.04
Outliers (%) 0.18
aggregation. We therefore decided to remove the GCN4
anchors. The construct lacking GCN4 (x2.1.2) yielded protein
that was amenable to crystallization. SEC-MALLS showed
that the purified PD1 was trimeric (Fig. 1d); the molecular
weight of the peak in the chromatogram was 45.6 kDa, as
determined from the UV, LS and dRI signals using the
ASTRA software (Wyatt). This is within experimental error
(5%) of the expected molecular weight of 47.8 kDa. It was
clear from the chromatogram that no aggregates were present,
and this construct yielded diffracting crystals (Supplementary
Fig. S4).
3.2. Structure of PD1
In our effort to characterize the full-length Hsf protein, we
determined the crystal structure of trimeric PD1 at a resolu-
tion of 3.3 A˚, thus providing the first insight into the molecular
arrangement of Hsf to date. HsfPD1 crystallized in the
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Figure 2
The crystal structure of HsfPD1 at 3.3 A˚ resolution. (a) HsfPD1 showing a trimeric architecture (three monomer subunits; blue, red and green). (b) One
HsfPD1 subunit with labelled secondary structure showing a novel domain arrangement: N-TrpRing:KG:TrpRing-C (proposed N-terminal TrpRing
domain, green; KG domain, red; C-terminal TrpRing, blue). (c) 29 N-terminal HsfPD1 residues superimpose on 29 C-terminal HsfPD1 residues with an
r.m.s.d. of 1.16 A˚ for the backbone (29 N-terminal residues, green; original C-terminal TrpRing, blue). W11–3, proposed novel TrpRing; KG1–3, KG-
domain helices [KG-domain -strand labels omitted for clarity in (b)]; W21–5, original TrpRing [W23 omitted for clarity in (c)].
monoclinic space group C2 (Table 1), with nine monomers in
the asymmetric unit. The crystals had an estimated solvent
content of 56.5%, with a Matthews coefficient (VM) of
2.83 A˚3 Da1. The number of residues identified in the density
of each monomer varied between 129 and 133 residues. The
missing loops in the monomers are owing to poor electron
density. Typical density is presented in Supplementary Fig. S3.
The individual monomers of HsfPD1 are comprised of three
distinct domains that fold to form well characterized TAA
domains. A proposed N-terminal TrpRing domain, a KG
domain and a C-terminal TrpRing domain are seen in each
PD1 monomer (Fig. 2b). The N-terminus of HsfPD1 spans 29
amino acids participating in the unexpected formation of three
-sheets, W11, W12 and W13 (where ‘W’ represents trypto-
phan), which share considerable structural homology with the
C-terminal TrpRing domain. Although the sequence identity
between these two regions is low (31%; Supplementary Fig.
S2), a structural alignment of the 29 N- and C-terminal resi-
dues from one HsfPD1 monomer (Fig. 2c) confirms that the
N-terminal region is indeed a TrpRing domain. The KG
domain is composed of two -strands, KG1 and KG2, as well
as three -helices, KG1, KG2 and KG3. The C-terminal
TrpRing is composed of five -strands: W21, W22, W23, W24
and W25. All domains participate in extensive intertwining,
where the C-terminal -helices (KG3) from each monomer
come together to create the central core of the trimer inter-
face. The KG and C-terminal TrpRing domains were easily
identified by simple structural observation and comparison
with other TAAs (Meng et al., 2008).
The TrpRing domains of TAAs are so named for the highly
conserved tryptophan residue that resides at the beginning of
the first -strand. Owing to the structural homology between
-sheets W11, W12, W13 and the C-terminal TrpRing, we
further analysed the full-length Hsf sequence and identified
a tryptophan residue 27 residues upstream of our HsfPD1
N-terminus. Since our construct contained only 29 N-terminal
residues upstream of the KG domain, and as TrpRing domains
typically consist of 55 amino acids, the structural evidence
suggests that our N-terminal -strands constitute the latter
half of a TrpRing domain. Additionally, the interleaved nature
of this proposed TrpRing domain and the fact that its N- and
C-termini lie close to the trimer axis support this hypothesis.
Prior to the solution of this structure, sequence analysis of
full-length Hsf resulted in the annotation of HsfPD1 as a
duplicate domain: N-KG:TrpRing-C (Singh et al., 2015).
However, our crystal structure indicates a novel triplicate
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Figure 3
Superposition of HsfPD1 with Hia307–422 and HiaBD1. (a) HsfPD1 aligns with Hia307–422 with an r.m.s.d. of 0.784 A˚ for the backbone, demonstrating
strong homology (HsfPD1, blue; Hia307–422, yellow). (b) HsfPD1 aligns with HiaBD1 with an r.m.s.d. of 0.969 A˚ for the backbone, clearly showing the
lack of IN3 in HsfPD1. HsfPD1, blue; HiaBD1, red.
domain arrangement for HsfPD1, N-TrpRing:KG:TrpRing-C,
an arrangement that is likely to extend to all Hsf putative
domains.
3.3. Comparison of HsfPD1 with HiaBD1 and Hia307–422
Hsf and Hia are remarkably similar in their domain
arrangement, as both possess adhesive domains (BDs) and
domains of unknown function (PDs). Whilst BD domains have
contiguous Neck-TrpRing architecture, the PD domains have
a KG domain instead of the Neck domain. The adhesive
activity of the BD domains in Hia results from the formation
of an acidic pocket created by residues Asp618 and Ala620 of
IN3, along with Val656 of the C-terminal TrpRing (Yeo et al.,
2004; Cotter et al., 2005). The substitution of the Neck domain
for KG domains abrogates the adhesive activity of PDs owing
to the lack of an equivalent -helix in KG to that of IN3 from
the Neck domain. Indeed, a superposition of HsfPD1 with the
non-adhesive head domain of Hia (PDB entry 3emi; Meng
et al., 2008) shows strong structural similarity (Fig. 3a). In
contrast, although a superposition of HsfPD1 with HiaBD1
(PDB entry 1s7m; Yeo et al., 2004) reveals modest structural
similarity, the acidic pocket created by IN3 is clearly missing
in HsfPD1 (Fig. 3b), suggesting that HsfPD1 is indeed a non-
adhesive domain.
3.4. Evolution of putative domains in Hia and Hsf
Owing to the high sequence identity between the shared
regions of Hia and Hsf (Supplementary Fig. S1), we predict
that, had the N-terminus of the Hia307–422 construct been
extended by 40 residues, the same N-TrpRing:KG:TrpRing-
C arrangement would have been observed. Moreover, this
triplicate arrangement indicates an evolutionary link between
BD and PD domains, in that BD domains are indeed tripli-
cates, i.e. N-TrpRing:Neck:TrpRing-C, and Hsf is approxi-
mately double the length of Hia. Thus, PD domains may have
evolved via the duplication of BD domains or vice versa. This
duplication certainly contributes to the overall length of Hsf,
and whilst it is consistently reported that the PD domains are
of unknown function, one implication of this evolution is that
the additional length created by these domains conveys a
survival advantage on those strains of H. influenzae that
express Hsf. This perhaps explains why Hsf is expressed by all
typeable strains ofH. influenzae (e.g. type b; Hib) whilst Hia is
not, i.e. it is long enough to extend beyond the bacterial
lipopolysaccharide layer and thus bind to complement regu-
lators and ECM molecules to evade attack by the host.
4. Conclusion
Although HsfPD1 is in many respects a typical TAA domain,
the novel domain arrangement (N-TrpRing:KG:TrpRing-C),
revealing the N-terminal TrpRing domain, demonstrates the
necessity of structural characterization of such proteins, as
opposed to sequence analysis alone. This arrangement yielded
insights into the evolution of PD domains, supporting the
divergent nature of TAAs, and supersedes the previous
domain annotation. Furthermore, the structure of HsfPD1 will
contribute to the understanding and determination of the
hypothesized ‘hairpin-like’ structure of Hsf. Inclusion of the
N-terminal TrpRing domain in computer models may help to
refine them. This combination may reveal unique protein–
protein interactions between antiparallel PD and BD domains,
generating exciting insights into the structure of TAAs, should
this novel hypothesis be true.
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